capecitabine has been researched along with Corneal Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bentley, E; Dubielzig, R; McAnulty, J; Milovancev, M; Schmiedt, C; Zarfoss, M | 1 |
| Fraunfelder, FT; Henner, WD; Waikhom, B; Walkhom, B | 1 |
2 other study(ies) available for capecitabine and Corneal Diseases
| Article | Year |
|---|---|
Histopathologic evidence of capecitabine corneal toxicity in dogs.
Topics: Animals; Capecitabine; Cornea; Corneal Diseases; Deoxycytidine; Dog Diseases; Dogs; Female; Fluorouracil; Immunosuppressive Agents; Kidney Transplantation | 2007 |
Severe ocular irritation and corneal deposits associated with capecitabine use.
Topics: Antineoplastic Agents; Breast Neoplasms; Capecitabine; Corneal Diseases; Deoxycytidine; Female; Fluorouracil; Humans; Keratitis; Keratoconjunctivitis Sicca; Middle Aged; Visual Acuity | 2000 |